Dioscorea vs Dioscorea Nipponica for mood
Short answer: For mood, more users report improvement with Dioscorea — 100% of 4 reports, versus 80% of 5 for Dioscorea Nipponica.
Dioscorea has 9 meta-analyses and 10 randomized trials on PubMed; Dioscorea Nipponica has 1 and 1.
Based on 20 reports about Dioscorea and 19 about Dioscorea Nipponica. Not medical advice.
| Dioscorea Supplement | Dioscorea Nipponica Supplement | |
|---|---|---|
| Users say it helped | 83%helped6 reports · few reports | 67%helped9 reports · few reports |
| Verdict | Mostly positive | Mostly positive |
| Research | AResearch: Strong | BResearch: Moderate |
| Meta-analyses / RCTs | 9 / 10 | 1 / 1 |
| Mainly used for | ||
| Mood % reporting improvement | 100% (4) | 80% (5) |
| Common side effects | bladder issues | hair loss, aggression, emotional instability |
| Typical dose reported | 2 capsules | 400 mg |
DCs and DEs exhibit broad-spectrum anticancer properties. In particular, dioscin exhibits low toxicity and exerts strong anticancer effects through multiple pathways and targets. Future studies should focus on investigating these DEs and DCs, especially dioscin, as a novel anticancer agent.
Phytomedicine, 2025 ↗“black ginger, horny goat weed, tribulus, dioscorea, cistamax, maca/black maca... they've all had crazy results when stacked in the bedroom for me”
DnM exerts multi-target effects by modulating key inflammatory and apoptotic pathways in ADs. The NF-κB, STAT3, and TGF-β/Smad signaling pathways may serve as key targets for DnM in modulating inflammatory states in ADs, while Fas/FasL and Bax/Bcl-2 are potential mediators of its apoptosis-regulating effects. Clinical evidence supports its efficacy in rheumatoid arthritis (RA) and Hashimoto's thyroiditis (HT), highlighting its multi-faceted therapeutic potential. This review systematically summarizes DnM's clinical outcomes, mechanisms, and toxicological profile, however, large-scale randomize
J Ethnopharmacol, 2025 ↗“It's hard to put a finger on its effects, but it's calming to me in a very unique way”
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate